Reuters logo
Juno says one patient dies during leukemia drug trial
2016年11月23日 / 下午1点17分 / 1 年前

Juno says one patient dies during leukemia drug trial

Nov 23 (Reuters) - Juno Therapeutics Inc said one patient had died and another was not expected to recover after suffering cerebral edema during a trial testing its experimental leukemia drug.

The company said on Wednesday that it had voluntarily put the trial on hold.

The drug, JCAR015, is being evaluated in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia, a type of blood cancer.

Trading in the company’s stock was halted. (Reporting by Natalie Grover in Bengaluru; Editing by Savio D‘Souza)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below